New hybrid theatre in University Hospital Limerick is at the cutting edge

David Hurley

Reporter:

David Hurley

Members of the multidisciplinary team at the new hybrid operating theatre at University Hospital Limerick. Picture: Liam Burke

Members of the multidisciplinary team at the new hybrid operating theatre at University Hospital Limerick. Picture: Liam Burke

THE vascular unit at University Hospital Limerick is now at the cutting edge following the opening of a new hybrid operating theatre.

The high-tech theatre, which was part-funded by the JP McManis Benevolent Fund, allows for shorter, minimally invasive procedures with better outcomes for vascular patients across the region.

85 surgical procedures have been carried out since it opened in May.

“The new hybrid theatre involved significant capital development, on-going key stakeholder engagement and extensive training programmes. The project was made possible by the continual commitment and dedication of all team members,” said Suzanne Dunne, head of strategy at UL Hospitals Group.

“This now takes UHL vascular surgery to the cutting edge. Combining hybrid imaging with advances in endovascular technologies will allow us to offer the full breath of minimally invasive vascular interventions to our patient,” said Tony Moloney one of four Consultant Vascular surgeons at UHL.

The new theatre includes a built-in, fixed imaging system and motorised image capable operating table in order to allow multidisciplinary management of vascular cases. Enhanced imaging is enabled by a fixed C-arm, allowing for imaging at multiple angles. Delivery of the Hybrid Theatre, ensures that UHL is at the forefront of technological advances and remains a leading centre for vascular/endovascular surgery in Ireland.

Colette Cowan, CEO, UL Hospitals Group, said: “Technology continues to revolutionise surgery and is contributing greatly to patient safety, improved outcomes and more efficient use of resources. Our surgeons are determined to keep up-to-date with developments and in this we have been generously supported by the Mid-Western Hospitals Development Trust and the JP McManus Benevolent Fund.